Lupin nelle notizie
Formulazioni e ingredienti farmaceutici
Tamtam ha trovato 20 articoli recenti su Lupin.
- Lupin Receives US FDA Approval for Amifampridine Tablets, 10 mg
- Lupin stock: Postal ballot seeks approval for Akhil Gupta's board seat
- Stock Picks Today: NSE, ABB India, Lupin, Syrma And More On Brokerages' Radar
- Lupin: Nomura raises target price to Rs 2,780, sees nearly 40% upside as valuations turn attractive
- Lupin seeks shareholder approval for Akhil Gupta's independent director role
- Buzzing stocks: Meesho, Clean Max, Lupin, IOC, NBCC, NCL Ind, Zee, Edelweiss, Jujhar Logistics, Ola
- Lupin Launches Ranibizumab Biosimilar Across Europe in Partnership with Sandoz
- Lupin launches biosimilar Ranibizumab in Europe
- Lupin announces European launch of biosimilar Ranluspec
- Lupin Announces European Launch of Biosimilar Ranibizumab - Lupin | Press Release
- European Commission Approves Lupin’s Ranibizumab Biosimilar
- Lupin’s partner debuts ranibizumab biosimilar in Europe
- Pharma sector stocks today, November 11: Alembic Pharma gains 2.82%; Divi's Laboratories falls 2.08%, Lupin down 1.25%
- Lupin Targets Complex Drugs To Drive Next Phase Of Growth, Plans Higher U.S. Manufacturing
- Accumulate Lupin; target of Rs 2250: Prabhudas Lilladher
- Broker’s Call: Lupin (Accumulate)
- Lupin Q2 Review: Systematix Revises Target Price, Remains Cautious On US Recovery
- Lupin Q2 Review: Jefferies Cuts Target 15%, Flags US Competition; Kotak Retains Add
- Propranolol: Cardinol LA 160 mg is changing to Propranolol LA Lupin
- Lupin Q2 net profit falls 22.19% to ₹1,155.3 crore
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come Lupin?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili